Quantitative residual cortical activity measurement: Appropriate test for diagnosis of renal artery stenosis?

Urologia Internationalis

Volumn 62, Issue 1, 1999, Pages 1-7

  Gezici, Ayten ^a   Ersay, Ahmet ^b   Antevska, Elizabetta ^a   Heidental, Guido K ^a   Schreij, Gerrit ^a   Demirtas, Omer Can ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Captopril renography; Renal artery stenosis; Residual cortical activity

Indexed keywords

CAPTOPRIL; TECHNESCAN; TECHNETIUM 99M; TECHNETIUM 99M MAG 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RENOGRAPHY; RENOVASCULAR HYPERTENSION;

EID: 0032772663     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030345     Document Type: Article

References (27)

1. Sfakianakis GN, Sfakianakis E, Bourgougnie JJ: Renal scintigraphy following angiotensin converting enzyme inhibition in the diagnosis of renovascular hypertension; in Freeman LM, Weissmann HS (eds): Nuclear Medicine Annual, 1988. New York, Raven Press, 1989, pp 125-170.
2. Blaufox MD: The role and rationale of nuclear medicine procedure in the differential diagnosis of renovascular hypertension. Nucl Med Biol 1992;8:583-587.
3. Dunnick NR, Sfakianakis GN: Screening for renovascular hypertension. Radiol Clin North Am 1991;29:479-510.
4. Sfakianakis GN, Georgious M, Cavagnaro F, Strauss J, Bourgougnie JJ: Fast protocols for obstruction and for renovascular hypertension. J Nucl Med Technol 1992;20:193-206.
5. Sfakianakis GN, Bourgougnie JJ, Jaffe DJ, Kryiakides G, Perez-Stable E, Duncan RC: Single dose captopril scintigraphy in the diagnosis of renovascular hypertension. J Nucl Med 1987;28:1383-1392.
6. 99mTc-MAG3) for detecting renal artery stenosis. Am J Hypertens 1991;4(suppl):737-740.
7. Nally JV Jr, Black HR: State of the art review. Captopril renography pathophysiological consideration and clinic observations. Semin Nucl Med 1992;22:85-97.
8. Sfakianakis GN, Bourgougnie JJ: Renographic diagnosis of renovascular hypertension with angiotensin-converting enzyme inhibition and furosemide. Am J Hypertens 1991;4:706-710.
9. Maan SJ, Pickering TG, Sos TA, Uzzo RG, Salil Sarkar BA, Friend K, Rackson ME: Captopril renography in the diagnosis of renal artery stenosis: Accuracy and limitations. Am J Med 1991;90:30-40.
10. Sfakianakis GN, Jaffe DJ, Bourgougnie JJ: Captopril scintigraphy in the diagnosis of renovascular hypertension. Kidney Int 1988;34: 142-144.
11. Dondi M, Monetti N, Fanti S, Marchetta F, Claudio C, Zagni P, DeFabritis A, Lassino F, Levorato M, Zuccala A: Use of technetium99m MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition. J Nucl Med 1991;32:424-428.
12. Working Group on Renovascular Hypertension: Detection, evaluation and treatment of renovascular hypertension. Final report. Arch Intern Med 1987;147:820-829.
13. Bookstein JJ, Abrams HL, Beunger RE, Reiss MD, Lecky JW, Franklin SS, Bleifer KH, Varady PD, Maxwell MH: Radiologie aspect of renovascular hypertension. Part 3. Appraisal of arteriography. JAMA 1972;221:368-374.
14. Klinge J, Mali WPTM, Puijlaert CBA, Geyskes GG, Becking WB, Feldberg MAM: Percutaneous transluminal renal angioplasty: Initial and long-term results. Radiology 1989;171: 839-848.
15. Nally JV, Chen C, Fine EJ, Fommei E, Chione S, Geyskes GG: Diagnostic criteria of renovascular hypertension with captopril renography. A consensus statement. Am J Hypertens 1991; 4:749-752.
16. Geyskes GG, Oei HY, Puylaert CB, Dorhout Mees EJ: Renovascular hypertension identified by captopril-induced changes in the renogram. Hypertension 1987;9:451-458.
17. Wenting GJ, Tan-Tjiong HL, Derkx FHM, DeBruyn JHB, Man In't Veld AJ, Schalekamp MADH: Split renal function after captopril in unilateral renal artery stenosis. Br Med J 1984; 288:886-890.
18. Svetkey LP, Himmelstein SI, Dunnick R, Wilkinson RH, Bollinger R: Prospective analysis of strategies for renovascular hypertension. Hypertension 1989;14:247-257.
19. Erbsloh B, Dumas A, Roth D, Sfakianakis GN, Bourgougnie JJ: Furosemide-131-Hippuran renography after ACE-inhibition for diagnosis of renovascular hypertension. Am J Med 1991; 90:23-29.
20. Dondi M, Franchi R, Levorato M, Zuccala A, Gaggi R, Mirelli M, Stella A, Marchetta F, Lossino F, Monetti N: Evaluation of hypertension patients by means of captopril enhanced renal scintigraphy with 99m-Tc DTPA. J Nucl Med 1989;30:615-621.
21. Setaro JF, Saddler MC, Chen CC: Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 1991;18:289-298.
22. Dondi M, Fanti S, De Fabritiis A, Zuccala A, Gaggi R, Mirelli M, Stella A, Marengo M, Lossino F, Monetti N: Prognostic value in captopril renal scintigraphy in renovascular hypertension. J Nucl Med 1993;33:2040-2044.
23. Dey HM, Hoffer PB, Lerner E, Zubal G, Setaro JF, Black HR: Quantitative analysis of the Tc 99-m DTPA captopril renogram J Nucl Med 1993;34:141-169.
24. Sfakianakis GN, Bourgougnie JJ, Georgious M, Guerra JJ: Diagnosis of renvascular hypertension with ACE inhibition scintigraphy. Radiol Clin North Am 1993;31:831-848.
25. Schreij G, Van Kroonenburgh M, Guido K, Heidendal GK, Harry A, Van der Pol AD, de Leeuw PW: Interpretation of captopril renography by nuclear medicine physicians. J Nucl Med 1995;36:2192-2195.
26. Schreij G, Ritsema GH, Vreugdenhil G, de Leeuw PW: Stenosis and renographic characteristics in renovascular disease. J Nucl Med 1996;37:594-597.
27. Ramsay LE, Waller PC: Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: An overview of published series. BMJ 1990;300:569-572.